A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study.
Eur J Cancer
; 195: 113373, 2023 12.
Article
in En
| MEDLINE
| ID: mdl-37890349
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
Eur J Cancer
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: